Cyclic di AMP phosphodiesterase nanovaccine elicits protective immunity against Burkholderia cenocepacia infection in mice

Abstract Burkholderia cenocepacia causes life-threatening infections in immunocompromised patients. Treatment is challenging due to intrinsic antibiotic multiresistance, so vaccination provides an alternative approach. We aimed to identify vaccine candidates using reverse vaccinology and evaluate th...

Full description

Saved in:
Bibliographic Details
Main Authors: Wesam E. Gawad, Yosra I. Nagy, Tamer M. Samir, Ahmed Mohamed Ibrahim Mansour, Omneya M. Helmy
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:npj Vaccines
Online Access:https://doi.org/10.1038/s41541-025-01074-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832572005389434880
author Wesam E. Gawad
Yosra I. Nagy
Tamer M. Samir
Ahmed Mohamed Ibrahim Mansour
Omneya M. Helmy
author_facet Wesam E. Gawad
Yosra I. Nagy
Tamer M. Samir
Ahmed Mohamed Ibrahim Mansour
Omneya M. Helmy
author_sort Wesam E. Gawad
collection DOAJ
description Abstract Burkholderia cenocepacia causes life-threatening infections in immunocompromised patients. Treatment is challenging due to intrinsic antibiotic multiresistance, so vaccination provides an alternative approach. We aimed to identify vaccine candidates using reverse vaccinology and evaluate their efficacy as protein-loaded chitosan: pectin nanoparticles (C:P NPs) in a vaccine model. Applying strict subtractive channels, three proteins were shortlisted: WP_006481710.1 (LY), WP_012493605.1 (KT), and WP_006492970.1 (BD). Proteins were cloned, purified as His-tagged proteins, and loaded onto C:P NPs. Vaccinated mice had significantly higher systemic IgG and mucosal IgA antibody responses and induced IL-6 and IL-17A. 6x-His-LY-CS:P NPs and 6x-His-KT-CS:P NPs vaccines induced TNF-α. Vaccines conferred significant protection against B. cenocepacia intranasal infections. In conclusion, cyclic-di-AMP phosphodiesterase (WP_012493605.1) is a promising vaccine candidate that elicited IgG and IgA antibodies, Th1, Th2, and Th17 cellular immunity in BALB/c mice and protected against B. cenocepacia infection. This provides hope for saving lives of people at high risk of infection.
format Article
id doaj-art-66c6057cdd454329993933958f4c5e94
institution Kabale University
issn 2059-0105
language English
publishDate 2025-02-01
publisher Nature Portfolio
record_format Article
series npj Vaccines
spelling doaj-art-66c6057cdd454329993933958f4c5e942025-02-02T12:07:33ZengNature Portfolionpj Vaccines2059-01052025-02-0110111610.1038/s41541-025-01074-4Cyclic di AMP phosphodiesterase nanovaccine elicits protective immunity against Burkholderia cenocepacia infection in miceWesam E. Gawad0Yosra I. Nagy1Tamer M. Samir2Ahmed Mohamed Ibrahim Mansour3Omneya M. Helmy4Department of Microbiology and Immunology, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and TechnologyDepartment of Microbiology and Immunology, Faculty of Pharmacy, Cairo UniversityDepartment of Microbiology and Immunology, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and TechnologyDepartment of Pharmacology and Toxicology, Faculty of Pharmacy (Boys), Al-Azhar UniversityDepartment of Microbiology and Immunology, Faculty of Pharmacy, Cairo UniversityAbstract Burkholderia cenocepacia causes life-threatening infections in immunocompromised patients. Treatment is challenging due to intrinsic antibiotic multiresistance, so vaccination provides an alternative approach. We aimed to identify vaccine candidates using reverse vaccinology and evaluate their efficacy as protein-loaded chitosan: pectin nanoparticles (C:P NPs) in a vaccine model. Applying strict subtractive channels, three proteins were shortlisted: WP_006481710.1 (LY), WP_012493605.1 (KT), and WP_006492970.1 (BD). Proteins were cloned, purified as His-tagged proteins, and loaded onto C:P NPs. Vaccinated mice had significantly higher systemic IgG and mucosal IgA antibody responses and induced IL-6 and IL-17A. 6x-His-LY-CS:P NPs and 6x-His-KT-CS:P NPs vaccines induced TNF-α. Vaccines conferred significant protection against B. cenocepacia intranasal infections. In conclusion, cyclic-di-AMP phosphodiesterase (WP_012493605.1) is a promising vaccine candidate that elicited IgG and IgA antibodies, Th1, Th2, and Th17 cellular immunity in BALB/c mice and protected against B. cenocepacia infection. This provides hope for saving lives of people at high risk of infection.https://doi.org/10.1038/s41541-025-01074-4
spellingShingle Wesam E. Gawad
Yosra I. Nagy
Tamer M. Samir
Ahmed Mohamed Ibrahim Mansour
Omneya M. Helmy
Cyclic di AMP phosphodiesterase nanovaccine elicits protective immunity against Burkholderia cenocepacia infection in mice
npj Vaccines
title Cyclic di AMP phosphodiesterase nanovaccine elicits protective immunity against Burkholderia cenocepacia infection in mice
title_full Cyclic di AMP phosphodiesterase nanovaccine elicits protective immunity against Burkholderia cenocepacia infection in mice
title_fullStr Cyclic di AMP phosphodiesterase nanovaccine elicits protective immunity against Burkholderia cenocepacia infection in mice
title_full_unstemmed Cyclic di AMP phosphodiesterase nanovaccine elicits protective immunity against Burkholderia cenocepacia infection in mice
title_short Cyclic di AMP phosphodiesterase nanovaccine elicits protective immunity against Burkholderia cenocepacia infection in mice
title_sort cyclic di amp phosphodiesterase nanovaccine elicits protective immunity against burkholderia cenocepacia infection in mice
url https://doi.org/10.1038/s41541-025-01074-4
work_keys_str_mv AT wesamegawad cyclicdiampphosphodiesterasenanovaccineelicitsprotectiveimmunityagainstburkholderiacenocepaciainfectioninmice
AT yosrainagy cyclicdiampphosphodiesterasenanovaccineelicitsprotectiveimmunityagainstburkholderiacenocepaciainfectioninmice
AT tamermsamir cyclicdiampphosphodiesterasenanovaccineelicitsprotectiveimmunityagainstburkholderiacenocepaciainfectioninmice
AT ahmedmohamedibrahimmansour cyclicdiampphosphodiesterasenanovaccineelicitsprotectiveimmunityagainstburkholderiacenocepaciainfectioninmice
AT omneyamhelmy cyclicdiampphosphodiesterasenanovaccineelicitsprotectiveimmunityagainstburkholderiacenocepaciainfectioninmice